Weili Zhao

46PUBLICATIONS
108CO-AUTHORS
Haematological tumoursSolid tumoursMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (46)

|Jul 27, 2026
Tumor molecular age acceleration is associated with early progression in diffuse large B-cell lymphoma.

|Jul 09, 2026
Intracellular iron homeostasis-regulated epigenetic reprogramming contributes to -7/del(7q) leukemia.

|Jun 29, 2026
LncRNA IRENA promotes peripheral T-cell lymphoma progression through scaffolding ARHGEF1 and FMNL1 to modulate RHOA GTPase/MAPK signaling.

|Jun 29, 2026
Extranodal natural killer/T-cell lymphoma: From fatal to curable.

|Jun 24, 2026
Tumor-infiltrating clonal hematopoiesis is associated with adverse clinical outcomes in diffuse large B-cell lymphoma.

|May 21, 2026
N6-methyladenosine reader IGF2BP2 in T-cell lymphoma.

Pageof 8

Frequent Collaborators

6 joint publications

Li Wang

4 joint publications

Rong-Ji Mu

4 joint publications

Jie Xiong

3 joint publications

Ting Niu